These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 34257565)
1. The Clinicopathological Significance of YAP/TAZ Expression in Hepatocellular Carcinoma with Relation to Hypoxia and Stemness. Park H; Lee Y; Lee K; Lee H; Yoo JE; Ahn S; Park YN; Kim H Pathol Oncol Res; 2021; 27():604600. PubMed ID: 34257565 [No Abstract] [Full Text] [Related]
2. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674 [TBL] [Abstract][Full Text] [Related]
3. Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis. Nahm JH; Kim H; Lee H; Cho JY; Choi YR; Yoon YS; Han HS; Park YN Tumour Biol; 2016 Jan; 37(1):393-403. PubMed ID: 26219896 [TBL] [Abstract][Full Text] [Related]
4. Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization. Rhee H; Nahm JH; Kim H; Choi GH; Yoo JE; Lee HS; Koh MJ; Park YN Mod Pathol; 2016 Sep; 29(9):1038-49. PubMed ID: 27312064 [TBL] [Abstract][Full Text] [Related]
5. Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. Wang H; Wang J; Zhang S; Jia J; Liu X; Zhang J; Wang P; Song X; Che L; Liu K; Ribback S; Cigliano A; Evert M; Wu H; Calvisi DF; Zeng Y; Chen X Cell Mol Gastroenterol Hepatol; 2021; 11(4):1095-1117. PubMed ID: 33232824 [TBL] [Abstract][Full Text] [Related]
6. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers. Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049 [TBL] [Abstract][Full Text] [Related]
7. TAZ is indispensable for c-MYC-induced hepatocarcinogenesis. Wang H; Zhang S; Zhang Y; Jia J; Wang J; Liu X; Zhang J; Song X; Ribback S; Cigliano A; Evert M; Liang B; Wu H; Calvisi DF; Zeng Y; Chen X J Hepatol; 2022 Jan; 76(1):123-134. PubMed ID: 34464659 [TBL] [Abstract][Full Text] [Related]
8. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role. Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258 [TBL] [Abstract][Full Text] [Related]
9. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression. Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216 [TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells. Li S; Li X; Yang YB; Wu SF Apoptosis; 2024 Aug; 29(7-8):1198-1210. PubMed ID: 38553612 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics. Kim H; Park YN Dig Dis; 2014; 32(6):778-85. PubMed ID: 25376296 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia after transarterial chemoembolization may trigger a progenitor cell phenotype in hepatocellular carcinoma. Lai JP; Conley A; Knudsen BS; Guindi M Histopathology; 2015 Oct; 67(4):442-50. PubMed ID: 25425262 [TBL] [Abstract][Full Text] [Related]
13. Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression. Rhee H; Chung T; Yoo JE; Nahm JH; Woo HY; Choi GH; Han DH; Park YN Hepatol Int; 2020 Mar; 14(2):239-248. PubMed ID: 31993941 [TBL] [Abstract][Full Text] [Related]
14. The Clinicopathological and Prognostic Significance of Nrf2 and Keap1 Expression in Hepatocellular Carcinoma. Lee K; Kim S; Lee Y; Lee H; Lee Y; Park H; Nahm JH; Ahn S; Yu SJ; Lee K; Kim H Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751896 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous knockdown of YAP and TAZ increases apoptosis of hepatocellular carcinoma cells under hypoxic condition. Yan B; Li T; Shen L; Zhou Z; Liu X; Wang X; Sun X Biochem Biophys Res Commun; 2019 Jul; 515(2):275-281. PubMed ID: 31146919 [TBL] [Abstract][Full Text] [Related]
16. Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma. Han SX; Bai E; Jin GH; He CC; Guo XJ; Wang LJ; Li M; Ying X; Zhu Q J Immunol Res; 2014; 2014():261365. PubMed ID: 24860833 [TBL] [Abstract][Full Text] [Related]
17. Differential requirement of Hippo cascade during CTNNB1 or AXIN1 mutation-driven hepatocarcinogenesis. Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500 [TBL] [Abstract][Full Text] [Related]
18. SEPTIN10-mediated crosstalk between cytoskeletal networks controls mechanotransduction and oncogenic YAP/TAZ signaling. Weiler SME; Bissinger M; Rose F; von Bubnoff F; Lutz T; Ori A; Schirmacher P; Breuhahn K Cancer Lett; 2024 Mar; 584():216637. PubMed ID: 38242197 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. Nahm JH; Rhee H; Kim H; Yoo JE; San Lee J; Jeon Y; Choi GH; Park YN Oncotarget; 2017 Nov; 8(59):99359-99371. PubMed ID: 29245907 [TBL] [Abstract][Full Text] [Related]
20. TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cells. Weiler SME; Lutz T; Bissinger M; Sticht C; Knaub M; Gretz N; Schirmacher P; Breuhahn K Cancer Lett; 2020 Mar; 473():164-175. PubMed ID: 31904487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]